Inventor · disambiguated record
In Cheol Kang
Also filed as: KANG IN C · KANG IN-CHEOL
7 granted patents·2 pending applications·25 citations·filing 1991–2023
76Inventor score
Top patents by PatentIndex Score
9 records- 0179US10278931B2Composition for treatment of inflammatory bowel disease and atopic dermatitisINNOPHARMASCREEN INC·Filed 2016·Granted May 7, 2019·2 cites·12 claims
- 0256US6537551B2Anti-tumor agent comprising salmosin as an active ingredientKIM DOO-SIK·Filed 2001·Granted Mar 25, 2003·2 cites·2 claims
- 0351US7604982B2High-throughput screening method for intergrin antagonist and new peptide screened therefromPROTEOGEN INC·Filed 2004·Granted Oct 20, 2009·0 cites·3 claims
- 0446US5143618AProcess for the treatment of organic wastewaterHYUNDAI ENGINEERING CO LTD·Filed 1991·Granted Sep 1, 1992·21 cites·5 claims
- 0542US12513346B2Method, system, and computer-readable recording medium for implementing fast-switching mode between channels in multi-live transmission environmentNAVER CORP·Filed 2023·Granted Dec 30, 2025·0 cites·15 claims
- 0642US10594583B2Bandwidth estimation based on buffer and adaptive bitrate publish in real-time live environmentNAVER CORP·Filed 2017·Granted Mar 17, 2020·0 cites·15 claims
- 0738US12219203B2Method, system, and computer readable recording medium for implementing seamless switching mode between channels in multi-stream live transmission environmentNAVER CORP·Filed 2021·Granted Feb 4, 2025·0 cites·15 claims
- 0834US2012101284A1Method for screening inhibitor for inhibiting interaction between beta-amyloid peptide and vegf and inhibitor searched by the sameKANG IN-CHEOL·Filed 2010·Application pending·0 cites
- 0929US2012264942A1Method for screening osteopontin inhibitor and inhibitor obtained from the methodKANG IN-CHEOL·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when In Cheol Kang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →